A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.

You may not qualify if:

• Patients who are pregnant, nursing, or planning a pregnancy within the study period.
• Patients who have more than 2 nodulo-cystic lesions on the face, excluding the nose.
• Patients who have a known hypersensitivity to any ingredients in the test products including clindamycin and benzoyl peroxide.
• Patients who have been treated with prescription and/or over-the-counter topical products, or had a procedure performed that may impact study assessments.
• Patients who have any systemic or dermatological disorder that has the potential to interfere with the evaluations (e.g., rosacea, seborrheic dermatitis, perioral dermatitis, corticosteroid-induced acne vulgaris, carcinoid syndrome, mastocytosis, acneform eruptions caused by medication, facial psoriasis, facial eczema, etc.).
• Patients with clinically significant unstable medical disorders, life-threatening disease, or current malignancies.
• Patients who engage in activities that involve excessive or prolonged exposure to sunlight.
• Patients who consume excessive amounts of alcohol, abuse drugs, or have any condition that would compromise compliance with this protocol.
• Patients who have been treated with an investigational drug or investigational device within a period of 30 days prior to study entry.
• Alcoholic toners, astringents, medicated topical preparations (prescriptions and over-the-counter), or medicated make-up on the facial treatment area.
• Abrasive cleansers or washes to the facial area.
• New cosmetics, or new cleansers applied to the face.
• Patients must not wear make-up at the visits, so as not to interfere with the evaluations.
• Patients should not use a sauna within 48 hours prior to each visit.